AIFORIA TECHNOLOGIES OYJ (L6J) - Net Assets
Based on the latest financial reports, AIFORIA TECHNOLOGIES OYJ (L6J) has net assets worth €17.05 Million EUR (≈ $19.93 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€29.16 Million ≈ $34.10 Million USD) and total liabilities (€12.11 Million ≈ $14.16 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. See L6J net asset quality index to measure how much of total assets are equity-financed.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €17.05 Million |
| % of Total Assets | 58.47% |
| Annual Growth Rate | -18.12% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 15.8 |
AIFORIA TECHNOLOGIES OYJ - Net Assets Trend (2021–2025)
This chart illustrates how AIFORIA TECHNOLOGIES OYJ's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see market cap of AIFORIA TECHNOLOGIES OYJ.
Annual Net Assets for AIFORIA TECHNOLOGIES OYJ (2021–2025)
The table below shows the annual net assets of AIFORIA TECHNOLOGIES OYJ from 2021 to 2025. Also explore AIFORIA TECHNOLOGIES OYJ equity growth rate to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €17.05 Million ≈ $19.93 Million |
+2.88% |
| 2024-12-31 | €16.57 Million ≈ $19.38 Million |
-7.45% |
| 2023-12-31 | €17.91 Million ≈ $20.94 Million |
-38.88% |
| 2022-12-31 | €29.30 Million ≈ $34.25 Million |
-22.78% |
| 2021-12-31 | €37.94 Million ≈ $44.36 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to AIFORIA TECHNOLOGIES OYJ's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4537500000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €78.25 Million | 458.93% |
| Total Equity | €17.05 Million | 100.00% |
AIFORIA TECHNOLOGIES OYJ Competitors by Market Cap
The table below lists competitors of AIFORIA TECHNOLOGIES OYJ ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Cnova NV
PA:CNV
|
$32.17 Million |
|
Vitreous Glass Inc
V:VCI
|
$32.19 Million |
|
Dental Corporation Public Company Limited
BK:D
|
$32.21 Million |
|
NovaBay Pharmaceuticals Inc
NYSE MKT:NBY
|
$32.22 Million |
|
Adcorp
JSE:ADR
|
$32.15 Million |
|
CL Educate Limited
NSE:CLEDUCATE
|
$32.14 Million |
|
InBioGen Co Ltd
KO:101140
|
$32.14 Million |
|
Imperial Equities Inc.
V:IEI
|
$32.13 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in AIFORIA TECHNOLOGIES OYJ's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 16,573,000 to 17,051,000, a change of 478,000 (2.9%).
- Net loss of 12,665,000 reduced equity.
- New share issuances of 12,399,000 increased equity.
- Other factors increased equity by 744,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-12.66 Million | -74.28% |
| Share Issuances | €12.40 Million | +72.72% |
| Other Changes | €744.00K | +4.36% |
| Total Change | €- | 2.88% |
Book Value vs Market Value Analysis
This analysis compares AIFORIA TECHNOLOGIES OYJ's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.51x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has increased from 0.56x to 1.51x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €1.46 | €0.81 | x |
| 2022-12-31 | €1.13 | €0.81 | x |
| 2023-12-31 | €0.69 | €0.81 | x |
| 2024-12-31 | €0.57 | €0.81 | x |
| 2025-12-31 | €0.54 | €0.81 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently AIFORIA TECHNOLOGIES OYJ utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -74.28%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -358.27%
- • Asset Turnover: 0.12x
- • Equity Multiplier: 1.71x
- Recent ROE (-74.28%) is below the historical average (-56.00%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -19.97% | -777.82% | 0.02x | 1.16x | €-11.37 Million |
| 2022 | -41.49% | -756.91% | 0.04x | 1.25x | €-15.09 Million |
| 2023 | -72.18% | -538.99% | 0.09x | 1.57x | €-14.72 Million |
| 2024 | -72.09% | -418.90% | 0.10x | 1.71x | €-13.60 Million |
| 2025 | -74.28% | -358.27% | 0.12x | 1.71x | €-14.37 Million |
Industry Comparison
This section compares AIFORIA TECHNOLOGIES OYJ's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $435,364,956
- Average return on equity (ROE) among peers: -573.58%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| AIFORIA TECHNOLOGIES OYJ (L6J) | €17.05 Million | -19.97% | 0.71x | $32.15 Million |
| YIDU TECH INC. DL -00002 (0EL) | $4.16 Billion | -15.11% | 0.18x | $441.11 Million |
| CERTIVE SOLUTIONS INC. (5CE) | $-7.74 Million | 0.00% | 0.00x | $253.72K |
| UPHEALTH INC (5XV) | $55.10 Million | -104.96% | 3.21x | $5.44 Million |
| IQ-AI LTD. LS -01 (5Y1) | $94.92K | -657.17% | 6.59x | $123.35K |
| Victory Square Technologies Inc (6F6) | $1.45 Million | -187.88% | 0.82x | $36.21 Million |
| NIGHTINGALE HEALTH EO 1 (7XE) | $66.17 Million | -27.90% | 0.13x | $34.97 Million |
| TRELLUS HEALTH LS -0006 (85Q) | $35.27 Million | -16.73% | 0.04x | $215.06K |
| SPOTLITE360 IOT SOLUTIONS (87A0) | $295.66K | -4766.19% | 10.32x | $916.43K |
| DocCheck AG (AJ91) | $17.99 Million | 6.05% | 0.17x | $56.32 Million |
| CompuGroup Medical SE & Co. KGaA (COP) | $28.87 Million | 34.15% | 3.77x | $1.17 Billion |
About AIFORIA TECHNOLOGIES OYJ
Aiforia Technologies Oyj, together with its subsidiary, Aiforia Inc., provides AI-based image analysis software used in clinical, preclinical, and academic laboratories to pathologists and researchers in Finland, rest of Europe, North America, and internationally. It offers tools for AI-supported diagnostics and visualization of patient samples, as well as automated screening and reporting tools … Read more